Utility of Th1-cell immune responses in differentiating active tuberculosis from latent tuberculosis infection

L. Zhang, Y. Song, Y. Zhang, Q. Li, M. Gao, X. Shi, Y. Zhang, Y. Zhang, A. Lalvani, X. Liu (Beijing, China; London, United Kingdom)

Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Session: Tuberculosis: from diagnosis to therapy and prevention
Session type: Poster Discussion
Number: 3061
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Zhang, Y. Song, Y. Zhang, Q. Li, M. Gao, X. Shi, Y. Zhang, Y. Zhang, A. Lalvani, X. Liu (Beijing, China; London, United Kingdom). Utility of Th1-cell immune responses in differentiating active tuberculosis from latent tuberculosis infection. Eur Respir J 2014; 44: Suppl. 58, 3061

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Immune response in children with latent tuberculosis infection and active pulmonary tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014


Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014


Utility of mycobacterium tuberculosis Rv0081-specific host gene expression to distinguish latent infection from active tuberculosis disease
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016

Combined phenotypical and functional analysis of M. tuberculosis specific immunity for diagnosing active infection and risk assessment in latently infected individuals
Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection
Year: 2014

Multiplexed cytokine and chemokine profiling in patients with latent tuberculosis infection: Treatment effect
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014

Biomarkers of systemic inflammatory response in patients with tuberculosis, combined with HIV infection
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016


Markers of cellular immunity in the diagnosis of tuberculosis pleurisy
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016


CD27 expression as a new tool to distinguish active tuberculosis from latent infection
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015


Evaluation of the accuracy of several immune experimental diagnostic tools to distinguish active tuberculosis from latent infection
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015

Pan-genomic and immunomic identification of novel mycobacterium tuberculosis antigens for TB diagnosis
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015

Unique cytokine profiles of CD4+T cell to Acr, HBHA and MDP-1 antigens in different clinical stage of mycobacterium tuberculosis infection
Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection
Year: 2014

The diagnosis of latent tuberculosis infection in children with new immunologic tests
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013


Comparative results of skin testing using tuberculosis allergen recombinant (CFP-10-ESAT-6) and QuantiFERON – GIT in children and adolescents with TB infection
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014


Glycopeptidolipids for evaluating the role of non-tuberculous mycobacteria in latent tuberculosis infection diagnosis
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013


Verification of pulmonary tuberculosis in HIV-infected patients with low CD4
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014

Cellular and humoral immune response in non HIV infected tuberculous patients in Upper Egypt
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015



Features detection of tuberculosis in HIV-patients in the region with a high prevalence of tuberculosis
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014

Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011

Correlation between tuberculin-skin-test and interferon-gamma-release-assays with risks factors for tuberculosis infection
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013


BCG vaccination in childhood is not related to pulmonary immunity against M. tuberculosis in adults
Source: International Congress 2014 – Tuberculosis: public health and primary prevention
Year: 2014